Education
About Us
Working with TipRanks
Follow Us
Morepen Laboratories Limited (IN:MOREPENLAB)
:MOREPENLAB
Total Valuation
Morepen Laboratories Limited has a market cap or net worth of ₹32.97B. The enterprise value is ₹12.99B.
Market Cap₹32.97B
Enterprise Value₹12.99B
Share Statistics
Morepen Laboratories Limited has 547,953,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding547,953,700
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Morepen Laboratories Limited’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 17.89%.
Return on Equity (ROE)0.10
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)17.89%
Return on Capital Employed (ROCE)0.25
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover1.03
Inventory Turnover4.00
Valuation Ratios
The current PE Ratio of Morepen Laboratories Limited is 22.45. Morepen Laboratories Limited’s PEG ratio is -0.51.
PE Ratio22.45
PS Ratio0.00
PB Ratio1.72
Price to Fair Value2.29
Price to FCF-9.45
Price to Operating Cash Flow-14.21
PEG Ratio-0.51
Income Statement
In the last 12 months, Morepen Laboratories Limited had revenue of 18.30B and earned 1.18B in profits. Earnings per share was 2.20.
Revenue18.30B
Gross Profit6.30B
Operating Income3.16B
Pretax Income1.55B
Net Income1.18B
EBITDA1.92B
Earnings Per Share (EPS)2.20
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Morepen Laboratories Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.64
52-Week Price Change11.47%
50-Day Moving Average60.88
200-Day Moving Average69.20
Relative Strength Index (RSI)45.06
Average Volume (3m)534.29K
Important Dates
Morepen Laboratories Limited upcoming earnings date is Aug 19, 2025, TBA Not Confirmed.
Last Earnings DateMay 12, 2025
Next Earnings DateAug 19, 2025
Ex-Dividend Date―
Financial Position
Morepen Laboratories Limited as a current ratio of 2.32, with Debt / Equity ratio of 3.34%
Current Ratio2.32
Quick Ratio1.72
Debt to Market Cap0.03
Net Debt to EBITDA0.29
Interest Coverage Ratio37.86
Taxes
In the past 12 months, Morepen Laboratories Limited has paid 370.94M in taxes.
Income Tax370.94M
Effective Tax Rate0.24
Enterprise Valuation
Morepen Laboratories Limited EV to EBITDA ratio is 14.06, with an EV/FCF ratio of -29.41.
EV to Sales1.48
EV to EBITDA14.06
EV to Free Cash Flow-29.41
EV to Operating Cash Flow84.37
Balance Sheet
Morepen Laboratories Limited has ₹1.27B in cash and marketable securities with ₹1.05B in debt, giving a net cash position of -₹220.72M billion.
Cash & Marketable Securities₹1.27B
Total Debt₹1.05B
Net Cash-₹220.72M
Net Cash Per Share-₹0.40
Tangible Book Value Per Share₹19.39
Margins
Gross margin is 32.58%, with operating margin of 17.26%, and net profit margin of 6.45%.
Gross Margin32.58%
Operating Margin17.26%
Pretax Margin8.48%
Net Profit Margin6.45%
EBITDA Margin10.52%
EBIT Margin8.93%
Analyst Forecast
The average price target for Morepen Laboratories Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―